ARCHIVES

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

This article is from The Cancer Letter archive.

Vol. 02 No. 40 | October 1, 1976

Download PDF Visit The Full Archive

Related Articles

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

Obituary: William Hutchinson, Cancer Center Founder

October 31, 1997

ASCO Guideline On Breast Cancer Risk Reduction Updated

May 29, 2009

Neutron Clinical Trials Contract Concept Approved

June 22, 1984

DCT Issues New Program Announcement On Clinical Research

December 5, 1980

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003